Login / Signup

Pembrolizumab as first-line therapy in programmed death ligand 1-positive advanced lung cancer: Is it as effective as we think it is?

Daniel A GoldsteinUsama BilalVinay Prasad
Published in: Cancer (2017)
Keyphrases
  • advanced non small cell lung cancer
  • stem cells